Estimation and extrapolation of optimal treatment and testing strategies

被引:153
作者
Robins, James [1 ,3 ]
Orellana, Liliana [2 ]
Rotnitzky, Andrea [3 ,4 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Univ Buenos Aires, FCEyN, Buenos Aires, DF, Argentina
[3] Di Tella Univ, Dept Econ, Buenos Aires, DF, Argentina
[4] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
关键词
dynamic regime; causal inference; marginal structural model; value of information;
D O I
10.1002/sim.3301
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We review recent developments in the estimation of an optimal treatment strategy or regime from longitudinal data collected in an observational study. We also propose novel methods for using the data obtained from an observational database in one health-care system to determine the optimal treatment regime I or biologically similar subjects in a second health-care system when, for cultural. logistical. or financial reasons, the two health-care systems differ (and will continue to differ) in the frequency of, and reasons tor, both laboratory tests and physician visits. Finally. we propose a novel method for estimating the optimal timing of expensive and/or painful diagnostic or prognostic tests. Diagnostic or prognostic tests are only useful in so far as they help a physician to determine the optimal dosing strategy, by providing information on both the current health state and the prognosis of a patient because, in contrast to drug therapies. these tests have no direct causal effect on disease progression. Our new method explicitly incorporates this no direct effect restriction. Copyright (C) 2008 John Wiley & Sons. Ltd.
引用
收藏
页码:4678 / 4721
页数:44
相关论文
共 15 条
[1]  
[Anonymous], 2006, INT J BIOSTAT
[2]   Comparison of dynamic treatment regimes via inverse probability weighting [J].
Hernán, MA ;
Lanoy, E ;
Costagliola, D ;
Robins, JM .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) :237-242
[3]  
Laan, 2006, UC BERKELEY DIVISION
[4]   Predictors identified for losses to follow-up among HIV-seropositive patients [J].
Lanoy, Emilie ;
Mary-Krause, Murielle ;
Tattevin, Pierre ;
Dray-Spira, Rosemary ;
Duvivier, Claudine ;
Fischer, Patricia ;
Obadia, Yolande ;
Lert, France ;
Costagliola, Dominique .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (08) :829-835
[5]   Demystifying optimal dynamic treatment regimes [J].
Moodie, Erica E. M. ;
Richardson, Thomas S. ;
Stephens, David A. .
BIOMETRICS, 2007, 63 (02) :447-455
[6]   Optimal dynamic treatment regimes [J].
Murphy, SA .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 2003, 65 :331-355
[7]  
Orellana L., 2006, GEN MARGINAL STRUCTU
[8]   Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata [J].
Palella, FJ ;
Deloria-Knoll, M ;
Chmiel, JS ;
Moorman, AC ;
Wood, KC ;
Greenberg, AE ;
Holmberg, SD .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) :620-626
[9]  
ROBINS J, 2004, P 2 SEATTL S BIOST S
[10]  
Robins J.M., 1992, AIDS EPIDEMIOLOGY ME